Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- Contingent fees (1)
- Disclosure (1)
- Education (1)
- Federal Election Commission (1)
- Fourth Amendment (1)
-
- Genetic tests (1)
- HIPAA (1)
- Health information (1)
- Justiciability (1)
- Lead paint litigation (1)
- Mandatory disclosure (1)
- Mass products plaintiffs’ attorneys (1)
- Parens patriae litigation (1)
- Physician-patient privilege (1)
- Privacy torts (1)
- Products litigation (1)
- Separation of powers (1)
- Sexual harassment (1)
- Software (1)
- State attorney general (1)
- Tobacco litigation (1)
- Torts (1)
- Voluntary disclosure (1)
- Publication
- Publication Type
Articles 1 - 4 of 4
Full-Text Articles in Law
Double Helix, Double Standards: Private Matters And Public People, Teneille R. Brown
Double Helix, Double Standards: Private Matters And Public People, Teneille R. Brown
Journal of Health Care Law and Policy
No abstract provided.
Tort Liability For Vendors Of Insecure Software: Has The Time Finally Come?, Michael D. Scott
Tort Liability For Vendors Of Insecure Software: Has The Time Finally Come?, Michael D. Scott
Maryland Law Review
No abstract provided.
Sexual Harassment In Education And Student Athletics: A Case For Why Title Ix Sexual Harassment Jurisprudence Should Develop Independently Of Title Vii, Michael E. Buchwald
Sexual Harassment In Education And Student Athletics: A Case For Why Title Ix Sexual Harassment Jurisprudence Should Develop Independently Of Title Vii, Michael E. Buchwald
Maryland Law Review
No abstract provided.
Impersonating The Legislature: State Attorneys General And Parens Patriae Product Litigation, Donald G. Gifford
Impersonating The Legislature: State Attorneys General And Parens Patriae Product Litigation, Donald G. Gifford
Faculty Scholarship
The state attorney general has emerged during the past decade as a “super plaintiff” in state parens patriae litigation against manufacturers of cigarettes, automobiles, lead paint, and pharmaceuticals. Attorneys general sue on behalf of their states as the collective plaintiff, seeking reimbursement for the costs of treating or preventing product-caused diseases suffered by individual residents, even though such individual victims would not themselves be able to recover as plaintiffs. More importantly, they seek to supplant the regulatory regimes previously enacted by Congress, the state legislature, or federal agencies with one that reflects their own visions. This Article traces how state …